Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olopatadine vs Azelastine in Vasomotor Rhinitis
NCT00979615Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Sep 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of olopatadine in vasomotor rhinitis (VMR) (2 arms), sponsored by Alcon Inc. Primary endpoint: Reflective Total Nasal Symptom Score at 2 weeks. Started Sep 2009; status: completed.
02
Drugs
olopatadine
03
Conditions
vasomotor rhinitis (VMR)
Beyond the preview
Go deeper on NCT00979615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979615.